Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Chronic Renal Failure

Free Subscription Articles published in Nephron Retrieve available abstracts of 129 articles: HTML format

Single Articles

March 2021
1. FOLKERTS K, Kelly AMB, Petruski-Ivleva N, Fried L, et al
   Cardiovascular and Renal Outcomes in Patients with Type-2 Diabetes and Chronic Kidney Disease Identified in a United States Administrative Claims Database: A Population Cohort Study.
   Nephron. 2021 Mar 31:1-11. doi: 10.1159/000513782.
   PubMed     Abstract available
   
   
   
2. DASHPUTRE AA, Sumida K, Potukuchi PK, Kar S, et al
   Potassium Trajectories prior to Dialysis and Mortality following Dialysis Initiation in Patients with Advanced CKD.
   Nephron. 2021 Mar 22:1-10. doi: 10.1159/000514294.
   PubMed     Abstract available
   
   
   
3. YANG KH, Cho S, Kim SR, Lee YJ, et al
   Serum Phosphorus Levels are Associated with Intradialytic Hypotension in Hemodialysis Patients.
   Nephron. 2021 Mar 4:1-7. doi: 10.1159/000513525.
   PubMed     Abstract available
   
   
   February 2021
4. SANABRIA RM, Hutchison CA, Vesga JI, Ariza JG, et al
   Expanded Hemodialysis and Its Effects on Hospitalizations and Medication Usage: A Cohort Study.
   Nephron. 2021;145:179-187.
   PubMed     Abstract available
   
   
   
5. GODI I, Lorenzin A, De Rosa S, Golino G, et al
   Vancomycin Adsorption During in vitro Model of Hemoperfusion with HA380 Cartridge.
   Nephron. 2021 Feb 10:1-7. doi: 10.1159/000513122.
   PubMed     Abstract available
   
   
   
6. OOKAWARA S, Ito K, Sasabuchi Y, Ueda Y, et al
   Association between Cerebral Oxygenation, as Evaluated with Near-Infrared Spectroscopy, and Cognitive Function in Patients Undergoing Hemodialysis.
   Nephron. 2021 Feb 8:1-8. doi: 10.1159/000513327.
   PubMed     Abstract available
   
   
   
7. LUBENNIKOV AE, Petrovskii NV, Krupinov GE, Shilov EM, et al
   Bilateral Nephrectomy in Patients with Autosomal Dominant Polycystic Kidney Disease and End-Stage Chronic Renal Failure.
   Nephron. 2021 Feb 5:1-7. doi: 10.1159/000513168.
   PubMed     Abstract available
   
   
   
8. VASQUEZ JIMENEZ E, Anumudu SJ, Neyra JA
   Dose of Continuous Renal Replacement Therapy in Critically Ill Patients: A Bona Fide Quality Indicator.
   Nephron. 2021 Feb 4:1-8. doi: 10.1159/000512846.
   PubMed     Abstract available
   
   
   December 2020
9. ELHADEDY MA, Marie Y, Halawa A
   COVID-19 in Renal Transplant Recipients: Case Series and a Brief Review of Current Evidence.
   Nephron. 2020 Dec 8:1-7. doi: 10.1159/000512329.
   PubMed     Abstract available
   
   
   
10. BOMHOLT T, Adrian T, Norgaard K, Ranjan AG, et al
    The Use of HbA1c, Glycated Albumin and Continuous Glucose Monitoring to Assess Glucose Control in the Chronic Kidney Disease Population Including Dialysis.
    Nephron. 2020 Dec 2:1-6. doi: 10.1159/000511614.
    PubMed     Abstract available
    
    
    
11. ARAI T, Oguchi H, Shinoda K, Sakurabayashi K, et al
    Clinicopathological Analysis of Acute/Active Antibody-Mediated Rejection in Renal Allografts According to the Banff 2013 Classification.
    Nephron. 2020;144 Suppl 1:18-27.
    PubMed     Abstract available
    
    
    
12. MORALES FEBLES R, Negrin Mena N, Rodriguez-Rodriguez AE, Diaz Martin L, et al
    Exercise and Prediabetes after Renal Transplantation (EXPRED): Protocol Description.
    Nephron. 2020 Dec 2:1-8. doi: 10.1159/000511320.
    PubMed     Abstract available
    
    
    
13. ONISHI H, Oguchi H, Shinoda K, Mikami T, et al
    Pathological Analysis of Early Transplant Glomerulopathy in Renal Allografts Using Low-Vacuum Scanning Electron Microscopy.
    Nephron. 2020 Dec 1:1-8. doi: 10.1159/000512136.
    PubMed     Abstract available
    
    
    November 2020
14. SAWADA A, Okumi M, Horita S, Unagami K, et al
    Glomerular Neovascularization in Nondiabetic Renal Allograft Is Associated with Calcineurin Inhibitor Toxicity.
    Nephron. 2020 Nov 25:1-6. doi: 10.1159/000511452.
    PubMed     Abstract available
    
    
    
15. ISOBE S, Tomosugi T, Futamura K, Okada M, et al
    A Case of Recurrent Atypical Anti-Glomerular Basement Membrane Nephritis Suspicion after Renal Transplantation.
    Nephron. 2020 Nov 25:1-5. doi: 10.1159/000511625.
    PubMed     Abstract available
    
    
    
16. HASHIMOTO J, Oguchi H, Mikami T, Hamasaki Y, et al
    Clinicopathological Analysis of Medullary Ray Injury in 1-Year Protocol Paediatric Renal Allograft Biopsies.
    Nephron. 2020 Nov 20:1-7. doi: 10.1159/000511917.
    PubMed     Abstract available
    
    
    October 2020
17. GADAEN RJR, Kooman JP, Cornelis T, van der Sande FM, et al
    The Effects of Chronic Dialysis on Physical Status, Quality of Life, and Arterial Stiffness: A Longitudinal Study in Prevalent Dialysis Patients.
    Nephron. 2020 Oct 27:1-11. doi: 10.1159/000510624.
    PubMed     Abstract available
    
    
    
18. BOMHOLT T, Idorn T, Knop FK, Jorgensen MB, et al
    The Glycemic Effect of Liraglutide Evaluated by Continuous Glucose Monitoring in Persons with Type 2 Diabetes Receiving Dialysis.
    Nephron. 2020 Oct 26:1-8. doi: 10.1159/000510613.
    PubMed     Abstract available
    
    
    
19. RICHERSON WT, Umfleet LG, Schmit BD, Wolfgram DF, et al
    Changes in Cerebral Volume and White Matter Integrity in Adults on Hemodialysis and Relationship to Cognitive Function.
    Nephron. 2020 Oct 13:1-9. doi: 10.1159/000510614.
    PubMed     Abstract available
    
    
    September 2020
20. OUGAARD ME, Sembach FE, Jensen HE, Pyke C, et al
    Liraglutide Improves the Kidney Function in a Murine Model of Chronic Kidney Disease.
    Nephron. 2020 Sep 2:1-12. doi: 10.1159/000509418.
    PubMed     Abstract available
    
    
    August 2020
21. RONCO C, Reis T, Cozzolino M
    Rationale for Medium Cutoff Membranes in COVID-19 Patients Requiring Renal Replacement Therapy.
    Nephron. 2020 Aug 4:1-5. doi: 10.1159/000509807.
    PubMed     Abstract available
    
    
    July 2020
22. LIM Y, Yang G, Cho S, Kim SR, et al
    Association between Ultrafiltration Rate and Clinical Outcome Is Modified by Muscle Mass in Hemodialysis Patients.
    Nephron. 2020 Jul 28:1-6. doi: 10.1159/000509350.
    PubMed     Abstract available
    
    
    
23. COX L, Wong E, Evans KM, Medcalf J, et al
    The Challenges of Using UK Renal Registry Data to Audit the Care of Patients with Diabetes on Renal Replacement Therapy.
    Nephron. 2020 Jul 22:1-7. doi: 10.1159/000508637.
    PubMed     Abstract available
    
    
    
24. LI CAVOLI G, Tortorici C, Bono L, Ferrantelli A, et al
    Comment on "Leptospirosis Renal Disease: Emerging Culprit of Chronic Kidney Disease Unknown Etiology".
    Nephron. 2020 Jul 6:1-2. doi: 10.1159/000509003.
    PubMed    
    
    
    June 2020
25. AKIZAWA T, Yamaguchi Y, Otsuka T, Reusch M, et al
    A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naive Chronic Kidney Disease Patients Not on Dialysis.
    Nephron. 2020 Jun 24:1-11. doi: 10.1159/000508100.
    PubMed     Abstract available
    
    
    
26. PISANI A, Rizzo M, Angelucci V, Riccio E, et al
    COVID-19 Experience in Hemodialysis Patients: A Cue for Therapeutic Heparin-Based Strategies?
    Nephron. 2020 Jun 11:1-3. doi: 10.1159/000508638.
    PubMed     Abstract available
    
    
    May 2020
27. CHISHOLM-BURNS MA, Spivey CA, Potukuchi PK, Streja E, et al
    Association between Posttransplant Opioid Use and Immunosuppressant Therapy Adherence among Renal Transplant Recipients.
    Nephron. 2020 May 20:1-10. doi: 10.1159/000507257.
    PubMed     Abstract available
    
    
    
28. SHAND JAD, Potter HC, Pilmore HL, Cundy T, et al
    Increased Peripheral Blood Heteroplasmy of the mt.3243A>G Mutation Is Associated with Earlier End-Stage Kidney Disease: A Case Report and Review of the Literature.
    Nephron. 2020 May 20:1-5. doi: 10.1159/000507732.
    PubMed     Abstract available
    
    
    
29. MURT A, Altiparmak MR
    Convalescent COVID-19 Patients on Hemodialysis: When Should We End Isolation?
    Nephron. 2020 May 19:1-2. doi: 10.1159/000508380.
    PubMed    
    
    
    
30. OSTOJIC SM
    Symmetric Dimethylarginine as a Secondary Prevention Biomarker of Chronic Kidney Disease.
    Nephron. 2020 May 12:1-2. doi: 10.1159/000507862.
    PubMed    
    
    
    March 2020
31. FU D, Yang B, Xu J, Mao Z, et al
    COVID-19 Infection in a Patient with End-Stage Kidney Disease.
    Nephron. 2020 Mar 27:1-3. doi: 10.1159/000507261.
    PubMed     Abstract available
    
    
    
32. OLOKO A, Talreja H, Davis A, McCormick B, et al
    Does Iodinated Contrast Affect Residual Renal Function in Dialysis Patients? A Systematic Review and Meta-Analysis.
    Nephron. 2020;144:1-9.
    PubMed     Abstract available
    
    
    February 2020
33. TSUJIMOTO Y, Tsutsumi Y, Ohnishi T, Kimachi M, et al
    Low Predialysis Plasma Calculated Osmolality Is Associated with Higher All-Cause Mortality: The Japanese Dialysis Outcomes and Practice Patterns Study (J-DOPPS).
    Nephron. 2020;144:138-146.
    PubMed     Abstract available
    
    
    January 2020
34. OLIVEIRA C, Mariz H, Fernandes G, Costa D, et al
    Lupus Nephritis Class IV-Global Is Associated with a Higher Risk of End-Stage Renal Disease than Class IV-Segmental.
    Nephron. 2020 Jan 7:1-8. doi: 10.1159/000505404.
    PubMed     Abstract available
    
    
    
35. SUN DQ, Wang TY, Zheng KI, Targher G, et al
    Subclinical Acute Kidney Injury in COVID-19 Patients: A Retrospective Cohort Study.
    Nephron. 2020;144:347-350.
    PubMed    
    
    
    
36. PYART R, Evans KM, Steenkamp R, Casula A, et al
    The 21st UK Renal Registry Annual Report: A Summary of Analyses of Adult Data in 2017.
    Nephron. 2020;144:59-66.
    PubMed    
    
    
    
37. PLUMB L, Casula A, Pyart R, Evans KM, et al
    The 21st UK Renal Registry Annual Report: A Summary of Analyses of Paediatric Data in 2017.
    Nephron. 2020;144:67-71.
    PubMed    
    
    
    
38. LORENZ R, Ahting U, Betzler C, Heimering S, et al
    Homoplasmy of the Mitochondrial DNA Mutation m.616T>C Leads to Mitochondrial Tubulointerstitial Kidney Disease and Encephalopathia.
    Nephron. 2020;144:156-160.
    PubMed     Abstract available
    
    
    September 2019
39. MITSIDES N, Alsehli FMS, Mc Hough D, Shalamanova L, et al
    Salt and Water Retention Is Associated with Microinflammation and Endothelial Injury in Chronic Kidney Disease.
    Nephron. 2019 Sep 12:1-9. doi: 10.1159/000502011.
    PubMed     Abstract available
    
    
    
40. DE VICO RIBEIRO B, Baggio Nerbass F, Chaud Hallvass AE, Pecoits-Filho R, et al
    Development and Validation of Equations to Estimate 24-H Urinary Sodium Excretion from Urine Samples of Patients with Chronic Kidney Disease.
    Nephron. 2019 Sep 5:1-9. doi: 10.1159/000502013.
    PubMed     Abstract available
    
    
    
41. ORTEGA-ROMERO M, Mendez-Hernandez P, Cruz-Angulo MDC, Hernandez-Sanchez AM, et al
    Chronic Kidney Disease in Children Aged 6-15 Years and Associated Risk Factors in Apizaco, Tlaxcala, Mexico, a Pilot Study.
    Nephron. 2019 Sep 5:1-10. doi: 10.1159/000502481.
    PubMed     Abstract available
    
    
    August 2019
42. VAN LOON IN, Goto NA, Boereboom FTJ, Bots ML, et al
    Geriatric Assessment and the Relation with Mortality and Hospitalizations in Older Patients Starting Dialysis.
    Nephron. 2019 Aug 13:1-12. doi: 10.1159/000501277.
    PubMed     Abstract available
    
    
    
43. AKIZAWA T, Macdougall IC, Berns JS, Yamamoto H, et al
    Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney Disease.
    Nephron. 2019 Aug 6:1-12. doi: 10.1159/000502012.
    PubMed     Abstract available
    
    
    July 2019
44. ABDELSALAM M, Tawfik M, Reda EM, Eldeeb AA, et al
    Insulin Resistance and Hepatitis C Virus-Associated Subclinical Inflammation Are Hidden Causes of Pruritus in Egyptian Hemodialysis Patients: A Multicenter Prospective Observational Study.
    Nephron. 2019 Jul 16:1-8. doi: 10.1159/000501409.
    PubMed     Abstract available
    
    
    June 2019
45. PADILLA-OROZCO M, Mendoza-Flores L, Herrera-Alonso A, Garza Gonzalez E, et al
    Generalized and Prolonged Use of Gentamicin-Lock Therapy Reduces Hemodialysis Catheter-Related Infections Due to Gram Negatives.
    Nephron. 2019 Jun 14:1-6. doi: 10.1159/000500549.
    PubMed     Abstract available
    
    
    
46. SILVARINO R, Rios P, Baldovinos G, Chichet MA, et al
    Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
    Nephron. 2019 Jun 14:1-8. doi: 10.1159/000500925.
    PubMed     Abstract available
    
    
    
47. KOJIMA M, Inaguma D, Koide S, Koshi-Ito E, et al
    Relationship between History of Ischemic Stroke and All-Cause Mortality in Incident Dialysis Patients.
    Nephron. 2019 Jun 11:1-11. doi: 10.1159/000500485.
    PubMed     Abstract available
    
    
    
48. FAYED A, Soliman A, El Mahdy H, Hamza W, et al
    Intraoperative Arterial Biopsy in Incident Hemodialysis Patients: Differences Observed.
    Nephron. 2019 Jun 6:1-8. doi: 10.1159/000500486.
    PubMed     Abstract available
    
    
    May 2019
49. AKIZAWA T, Nangaku M, Yamaguchi T, Arai M, et al
    Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial.
    Nephron. 2019 May 22:1-9. doi: 10.1159/000500487.
    PubMed     Abstract available
    
    
    
50. SUN L, Ji Y, Wang Y, Zhu D, et al
    Development and Internal Validation of a Prediction Model to Estimate the Probability of Left-Ventricular Diastolic Dysfunction in Stable Maintenance Hemodialysis Patients without Clinical Heart Failure.
    Nephron. 2019 May 2:1-10. doi: 10.1159/000499605.
    PubMed     Abstract available
    
    
    April 2019
51. GEWIN LS
    Transforming Growth Factor-beta in the Acute Kidney Injury to Chronic Kidney Disease Transition.
    Nephron. 2019 Apr 30:1-4. doi: 10.1159/000500093.
    PubMed     Abstract available
    
    
    
52. CHAGNAC A, Zingerman B, Rozen-Zvi B, Herman-Edelstein M, et al
    Consequences of Glomerular Hyperfiltration: The Role of Physical Forces in the Pathogenesis of Chronic Kidney Disease in Diabetes and Obesity.
    Nephron. 2019 Apr 4:1-5. doi: 10.1159/000499486.
    PubMed     Abstract available
    
    
    March 2019
53. TIMMERMANS SAMEG, van Paassen P
    Mother and Child Reunion in "Hypertensive" End-Stage Renal Disease: Will They Complement Each Other?
    Nephron. 2019 Mar 14:1-5. doi: 10.1159/000497779.
    PubMed     Abstract available
    
    
    February 2019
54. TODA A, Hara S, Kato M, Tsuji H, et al
    Association of Thyrotropin Concentration with Chronic Kidney Disease in a Japanese General Population Cohort.
    Nephron. 2019 Feb 22:1-7. doi: 10.1159/000497326.
    PubMed     Abstract available
    
    
    
55. YALIN SF, Eren N, Sinangil A, Yilmaz VT, et al
    Fabry Disease Prevalence in Renal Replacement Therapy in Turkey.
    Nephron. 2019 Feb 8:1-8. doi: 10.1159/000496620.
    PubMed     Abstract available
    
    
    
56. OKUNO S, Inaba M, Ishimura E, Nakatani S, et al
    Effects of Long-Term Cinacalcet Administration on Parathyroid Gland in Hemodialysis Patients with Secondary Hyperparathyroidism.
    Nephron. 2019 Feb 1:1-8. doi: 10.1159/000496808.
    PubMed     Abstract available
    
    
    
57. MATSUURA R, Doi K, Komaru Y, Miyamoto Y, et al
    Endogenous Erythropoietin and Hepatic Dysfunction in Acute Kidney Injury Requiring Renal Replacement Therapy.
    Nephron. 2019 Feb 1:1-7. doi: 10.1159/000496618.
    PubMed     Abstract available
    
    
    January 2019
58. MILAN MANANI S, Rosner MH, Virzi GM, Giuliani A, et al
    Longitudinal Experience with Remote Monitoring for Automated Peritoneal Dialysis Patients.
    Nephron. 2019 Jan 30:1-9. doi: 10.1159/000496182.
    PubMed     Abstract available
    
    
    
59. MOISEEV S, Fomin V, Savostyanov K, Pushkov A, et al
    The Prevalence and Clinical Features of Fabry Disease in Hemodialysis Patients: Russian Nationwide Fabry Dialysis Screening Program.
    Nephron. 2019 Jan 24:1-7. doi: 10.1159/000495886.
    PubMed     Abstract available
    
    
    
60. BOAZ M, Azoulay O, Schwartz IF, Schwartz D, et al
    Malnutrition Risk in Hemodialysis Patients in Israel: Results of the Status of Nutrition In Hemodialysis Patients Survey Study.
    Nephron. 2019 Jan 17:1-11. doi: 10.1159/000495150.
    PubMed     Abstract available
    
    
    
61. STOZER A, Hojs R, Dolensek J
    Beta Cell Functional Adaptation and Dysfunction in Insulin Resistance and the Role of Chronic Kidney Disease.
    Nephron. 2019 Jan 16:1-5. doi: 10.1159/000495665.
    PubMed     Abstract available
    
    
    
62. DRATCH A, Kleine CE, Streja E, Soohoo M, et al
    Mean Corpuscular Volume and Mortality in Incident Hemodialysis Patients.
    Nephron. 2019 Jan 9:1-13. doi: 10.1159/000495726.
    PubMed     Abstract available
    
    
    
63. SANYANG Y, Sambou M
    Maintenance Haemodialysis in the Edward Francis Small Teaching Hospital in the Gambia.
    Nephron. 2019;142:114-116.
    PubMed     Abstract available
    
    
    
64. ALBERT C, Kube J, Albert A, Schanze D, et al
    Cubilin Single Nucleotide Polymorphism Variants are Associated with Macroangiopathy While a Matrix Metalloproteinase-9 Single Nucleotide Polymorphism Flip-Flop may Indicate Susceptibility of Diabetic Nephropathy in Type-2 Diabetic Patients.
    Nephron. 2019;141:156-165.
    PubMed     Abstract available
    
    
    December 2018
65. NIXON AC, Bampouras TM, Pendleton N, Mitra S, et al
    Diagnostic Accuracy of Frailty Screening Methods in Advanced Chronic Kidney Disease.
    Nephron. 2018 Dec 14:1-9. doi: 10.1159/000494223.
    PubMed     Abstract available
    
    
    November 2018
66. SAEED F, Arrigain S, Schold JD, Nally JV Jr, et al
    What are the Risk Factors for One-Year Mortality in Older Patients with Chronic Kidney Disease? An Analysis of the Cleveland Clinic CKD Registry.
    Nephron. 2018 Nov 21:1-7. doi: 10.1159/000494298.
    PubMed     Abstract available
    
    
    
67. CHIU CW, Tsai TH, Lin CL, Yen TH, et al
    Icodextrin is Associated with a Lower Risk of Stroke in Peritoneal Dialysis Patients.
    Nephron. 2018 Nov 13:1-7. doi: 10.1159/000494511.
    PubMed     Abstract available
    
    
    
68. LIM SY, Lee KB, Kim H, Hyun YY, et al
    Low Skeletal Muscle Mass Predicts Incident Dipstick Albuminuria in Korean Adults without Chronic Kidney Disease: A Prospective Cohort Study.
    Nephron. 2018 Nov 9:1-7. doi: 10.1159/000494392.
    PubMed     Abstract available
    
    
    
69. GOTO NA, van Loon IN, Morpey MI, Verhaar MC, et al
    Geriatric Assessment in Elderly Patients with End-Stage Kidney Disease.
    Nephron. 2018 Nov 1:1-8. doi: 10.1159/000494222.
    PubMed     Abstract available
    
    
    October 2018
70. CHAUDHURY P, Armanyous S, Harb SC, Ferreira Provenzano L, et al
    Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis.
    Nephron. 2018 Oct 26:1-10. doi: 10.1159/000494047.
    PubMed     Abstract available
    
    
    
71. HUTCHISON A, Whelton A, Thadhani R, Achenbach H, et al
    Long-Term Mortality and Bone Safety in Patients with End-Stage Renal Disease Receiving Lanthanum Carbonate.
    Nephron. 2018 Oct 23:1-10. doi: 10.1159/000492603.
    PubMed     Abstract available
    
    
    
72. ISEKI K, Henn LL, Nomura T, Kanda E, et al
    Dialysate Calcium Concentration below 3.0 mEq/L Is Not Associated with Improved Outcomes in the Japanese Dialysis Outcomes and Practice Patterns Study.
    Nephron. 2018 Oct 19:1-9. doi: 10.1159/000493470.
    PubMed     Abstract available
    
    
    
73. TROJANOWICZ B, Imdahl T, Ulrich C, Fiedler R, et al
    Circulating miR-421 Targeting Leucocytic Angiotensin Converting Enzyme 2 Is Elevated in Patients with Chronic Kidney Disease.
    Nephron. 2018 Oct 16:1-14. doi: 10.1159/000493805.
    PubMed     Abstract available
    
    
    September 2018
74. LEVIN A, Nair D, Qureshi AR, Barany P, et al
    Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot Study.
    Nephron. 2018 Sep 25:1-8. doi: 10.1159/000492500.
    PubMed     Abstract available
    
    
    
75. DE ROIJ VAN ZUIJDEWIJN CLM, de Haseth DE, van Dam B, Bax WA, et al
    Role of Albumin Assay on Calcium Levels and Prescription of Phosphate Binders in Chronic Hemodialysis Patients.
    Nephron. 2018 Sep 13:1-7. doi: 10.1159/000492238.
    PubMed     Abstract available
    
    
    
76. ABDELSALAM M, Elnagar SSE, Mohamed AH, Tawfik M, et al
    Community Acquired Acute Kidney Injury in Mansoura Nephrology Dialysis Unit: One Year Prospective Observational Study.
    Nephron. 2018 Sep 11:1-9. doi: 10.1159/000492063.
    PubMed     Abstract available
    
    
    August 2018
77. SHIMIZU S, Fukuma S, Ikenoue T, Akizawa T, et al
    Increased Mortality Rate after Hospitalization Among Chronic Hemodialysis Patients: A Prospective Cohort Study.
    Nephron. 2018 Aug 28:1-9. doi: 10.1159/000492083.
    PubMed     Abstract available
    
    
    
78. TSAI MH, Hsu CY, Lin MY, Yen MF, et al
    Incidence, Prevalence, and Duration of Chronic Kidney Disease in Taiwan: Results from a Community-Based Screening Program of 106,094 Individuals.
    Nephron. 2018 Aug 23:1-10. doi: 10.1159/000491708.
    PubMed     Abstract available
    
    
    July 2018
79. COZZOLINO M, Bolasco P, Ronco C, Conte G, et al
    Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE Study.
    Nephron. 2018 Jul 17:1-9. doi: 10.1159/000490769.
    PubMed     Abstract available
    
    
    
80. OTSUKI T, Utsunomiya K, Moriuchi M, Horikoshi S, et al
    Effect of Sucroferric Oxyhydroxide on Fibroblast Growth Factor 23 Levels in Hemodialysis Patients.
    Nephron. 2018 Jul 10:1-8. doi: 10.1159/000490903.
    PubMed     Abstract available
    
    
    
81. TANDUKAR S, Fried LF
    Dyskalemia in Chronic Kidney Disease: How Concerned Should We Be?
    Nephron. 2018 Jul 4:1-5. doi: 10.1159/000490008.
    PubMed     Abstract available
    
    
    June 2018
82. GRITTER M, Vogt L, Yeung SMH, Wouda RD, et al
    Rationale and Design of a Randomized Placebo-Controlled Clinical Trial Assessing the Renoprotective Effects of Potassium Supplementation in Chronic Kidney Disease.
    Nephron. 2018 Jun 29:1-10. doi: 10.1159/000490261.
    PubMed     Abstract available
    
    
    
83. FULLER DS, Robinson BM, Locatelli F, Pisoni RL, et al
    Patterns of Erythropoiesis-Stimulating Agent Use in European Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study.
    Nephron. 2018 Jun 26:1-7. doi: 10.1159/000490202.
    PubMed     Abstract available
    
    
    
84. FUJISAKI K, Tanaka S, Taniguchi M, Matsukuma Y, et al
    Study on Dialysis Session Length and Mortality in Maintenance Hemodialysis Patients: The Q-Cohort Study.
    Nephron. 2018 Jun 7:1-8. doi: 10.1159/000489680.
    PubMed     Abstract available
    
    
    
85. KUCZERA P, Adamczak M, Machnik G, Okopien B, et al
    Treatment Based on Cinacalcet Reduces Oxidative Stress in Hemodialysis Patients with Secondary Hyperparathyroidism.
    Nephron. 2018 Jun 7:1-7. doi: 10.1159/000489278.
    PubMed     Abstract available
    
    
    
86. STRINGUETTA BELIK F, Oliveira E Silva VR, Braga GP, Bazan R, et al
    Influence of Intradialytic Aerobic Training in Cerebral Blood Flow and Cognitive Function in Patients with Chronic Kidney Disease: A Pilot Randomized Controlled Trial.
    Nephron. 2018 Jun 7:1-9. doi: 10.1159/000490005.
    PubMed     Abstract available
    
    
    May 2018
87. BIKBOV B, Perico N, Remuzzi G
    Disparities in Chronic Kidney Disease Prevalence among Males and Females in 195 Countries: Analysis of the Global Burden of Disease 2016 Study.
    Nephron. 2018 May 23:1-6. doi: 10.1159/000489897.
    PubMed     Abstract available
    
    
    April 2018
88. TRABULUS S, Oruc M, Ozgun E, Altiparmak MR, et al
    The Use of Low-Calcium Hemodialysis in the Treatment of Hypercalcemic Crisis.
    Nephron. 2018 Apr 19. pii: 000488502. doi: 10.1159/000488502.
    PubMed     Abstract available
    
    
    
89. LIM SY, Ko YS, Lee HY, Yang JH, et al
    The Impact of Preexisting Chronic Kidney Disease on the Severity and Recovery of Acute Kidney Injury.
    Nephron. 2018 Apr 12. pii: 000487492. doi: 10.1159/000487492.
    PubMed     Abstract available
    
    
    
90. LI CAVOLI G, Oliva B, Caputo F
    Dialysis Modality towards Kidney Transplant Outcomes.
    Nephron. 2018 Apr 3. pii: 000488503. doi: 10.1159/000488503.
    PubMed    
    
    
    March 2018
91. SAENGPANIT D, Chattranukulchai P, Tumkosit M, Siribumrungwong M, et al
    Effect of Sodium Thiosulfate on Arterial Stiffness in End-Stage Renal Disease Patients Undergoing Chronic Hemodialysis (Sodium Thiosulfate-Hemodialysis Study): A Randomized Controlled Trial.
    Nephron. 2018 Mar 23. pii: 000488009. doi: 10.1159/000488009.
    PubMed     Abstract available
    
    
    
92. MAJOR RW, Shepherd D, Brunskill NJ
    Reclassification of Chronic Kidney Disease Stage, Eligibility for Cystatin-C and Its Associated Costs in a UK Primary Care Cohort.
    Nephron. 2018;139:39-46.
    PubMed     Abstract available
    
    
    
93. TIRANATHANAGUL K, Susantitaphong P, Srisawat N, Mahatanan N, et al
    Ten-Year Survival of End-Stage Renal Disease Patients Treated with High-Efficiency Online Hemodiafiltration: A Cohort Study of a Center in South East Asia.
    Nephron. 2018 Mar 7. pii: 000487364. doi: 10.1159/000487364.
    PubMed     Abstract available
    
    
    
94. GREEVIROJ P, Kitrungphaiboon T, Katavetin P, Praditpornsilpa K, et al
    Cinacalcet for Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: A Meta-Analysis of Randomized Controlled Trials.
    Nephron. 2018 Mar 7. pii: 000487546. doi: 10.1159/000487546.
    PubMed     Abstract available
    
    
    
95. NEZAMI N, Ghabili K, Shokouhi-Gogani B, Mirchi M, et al
    The Relationship between Carotid and Femoral Artery Intima-Media Thickness and Histopathologic Grade of Atherosclerosis in Patients with Chronic Kidney Disease.
    Nephron. 2018 Mar 7. pii: 000487491. doi: 10.1159/000487491.
    PubMed     Abstract available
    
    
    February 2018
96. LIU H, Lu R, Shastri S, Sonderman M, et al
    Assessing Extracellular Volume in Hemodialysis Patients Using Intradialytic Blood Pressure Slopes.
    Nephron. 2018 Feb 13. pii: 000487093. doi: 10.1159/000487093.
    PubMed     Abstract available
    
    
    
97. KOVAROVA L, Valerianova A, Kmentova T, Lachmanova J, et al
    Low Cerebral Oxygenation Is Associated with Cognitive Impairment in Chronic Hemodialysis Patients.
    Nephron. 2018 Feb 13. pii: 000487092. doi: 10.1159/000487092.
    PubMed     Abstract available
    
    
    
98. CALVINO J, Cigarran S, Gonzalez-Tabares L, Guijarro M, et al
    Restless Legs Syndrome: An Unresolved Uremic Disorder after Renal Transplantation.
    Nephron. 2018 Feb 1. pii: 000486401. doi: 10.1159/000486401.
    PubMed     Abstract available
    
    
    January 2018
99. ROZENBAUM Z, Benchetrit S, Rozenbaum E, Neumark E, et al
    Ultra-Low Contrast Volume for Patients with Advanced Chronic Kidney Disease Undergoing Coronary Procedures.
    Nephron. 2018 Jan 24. pii: 000485648. doi: 10.1159/000485648.
    PubMed     Abstract available
    
    
    
100. KIM TW, Chang TI, Kim TH, Chou JA, et al
     Association of Ultrafiltration Rate with Mortality in Incident Hemodialysis Patients.
     Nephron. 2018 Jan 18. pii: 000486323. doi: 10.1159/000486323.
     PubMed     Abstract available
     
     
     
101. HICKSON LJ, Thorsteinsdottir B, Ramar P, Reinalda MS, et al
     Hospital Readmission among New Dialysis Patients Associated with Young Age and Poor Functional Status.
     Nephron. 2018 Jan 9. pii: 000485985. doi: 10.1159/000485985.
     PubMed     Abstract available
     
     
     
102. WALLQUIST C, Mansouri L, Norrback M, Hylander B, et al
     Associations of Fibroblast Growth Factor 23 with Markers of Inflammation and Leukocyte Transmigration in Chronic Kidney Disease.
     Nephron. 2018 Jan 4. pii: 000485472. doi: 10.1159/000485472.
     PubMed     Abstract available
     
     
     
103. 
     Appendix E Methodology for Estimating Catchment Populations of Renal Centres in the UK for Dialysis.
     Nephron. 2018;139 Suppl 1:305-308.
     PubMed    
     
     
     
104. HOLE B, Magadi W, Steenkamp R, Fluck R, et al
     Chapter 10 Multisite Dialysis Access Audit in England, Northern Ireland and Wales and 2015 Peritoneal.
     Nephron. 2018;139 Suppl 1:253-272.
     PubMed    
     
     
     
105. PYART R, Casula A, Nicholas J, Dawnay A, et al
     Chapter 8 Biochemical Variables in UK Adult Dialysis Patients in 2016: National and Centre-specific.
     Nephron. 2018;139 Suppl 1:191-240.
     PubMed    
     
     
     
106. PYART R, Gilg J, Williams AJ
     Chapter 7 Haemoglobin, Ferritin and Erythropoietin in UK Adult Dialysis Patients in 2016: National and.
     Nephron. 2018;139 Suppl 1:165-190.
     PubMed    
     
     
     
107. PLUMB L, Casula A, Magadi W, Braddon F, et al
     Chapter 11 Clinical, Haematological and Biochemical Parameters in Patients on Renal Replacement Therapy.
     Nephron. 2018;139 Suppl 1:273-286.
     PubMed    
     
     
     
108. STEENKAMP R, Pyart R, Fraser S
     Chapter 5 Survival and Cause of Death in UK Adult Patients on Renal Replacement Therapy in 2016.
     Nephron. 2018;139 Suppl 1:117-150.
     PubMed    
     
     
     
109. PLUMB L, Wong E, Casula A, Braddon F, et al
     Chapter 4 Demography of the UK Paediatric Renal Replacement Therapy Population in 2016.
     Nephron. 2018;139 Suppl 1:105-116.
     PubMed    
     
     
     
110. MACNEILL SJ, Ford D, Evans K, Medcalf JF, et al
     Chapter 2 UK Renal Replacement Therapy Adult Prevalence in 2016: National and Centre-specific Analyses.
     Nephron. 2018;139 Suppl 1:47-74.
     PubMed    
     
     
     
111. HOLE B, Gilg J, Casula A, Methven S, et al
     Chapter 1 UK Renal Replacement Therapy Adult Incidence in 2016: National and Centre-specific Analyses.
     Nephron. 2018;139 Suppl 1:13-46.
     PubMed    
     
     
     December 2017
112. LEW QLJ, Allen JC, Nguyen F, Tan NC, et al
     Factors Associated with Chronic Kidney Disease and Their Clinical Utility in Primary Care Clinics in a Multi-Ethnic Southeast Asian Population.
     Nephron. 2017 Dec 15. pii: 000485110. doi: 10.1159/000485110.
     PubMed     Abstract available
     
     
     
113. MA TK, Chow KM, Kwan BC, Ng JK, et al
     Peritoneal Dialysis Catheter Revision and Replacement by Nephrologist for Peritoneal Dialysis Catheter Malfunction.
     Nephron. 2017 Dec 14. pii: 000485643. doi: 10.1159/000485643.
     PubMed     Abstract available
     
     
     
114. BAKKALOGLU SA, Ozdemir Atikel Y, Paglialonga F, Stefanidis CJ, et al
     Vaccination Practices in Pediatric Dialysis Patients Across Europe. A European Pediatric Dialysis Working Group and European Society for Pediatric Nephrology Dialysis Working Group Study.
     Nephron. 2017 Dec 12. pii: 000485398. doi: 10.1159/000485398.
     PubMed     Abstract available
     
     
     November 2017
115. EL-HUSSEINI A, Wang K, Edon A, Saxon D, et al
     Value of Intraoperative Parathyroid Hormone Assay during Parathyroidectomy in Dialysis and Renal Transplant Patients with Secondary and Tertiary Hyperparathyroidism.
     Nephron. 2017 Nov 9. doi: 10.1159/000482016.
     PubMed     Abstract available
     
     
     
116. AKRAWI DS, PirouziFard M, Fjellstedt E, Sundquist J, et al
     Heritability of End-Stage Renal Disease: A Swedish Adoption Study.
     Nephron. 2017 Nov 9. doi: 10.1159/000484327.
     PubMed     Abstract available
     
     
     October 2017
117. POURAFSHAR N, Pourafshar S, Soleimani M
     Urine Ammonium, Metabolic Acidosis and Progression of Chronic Kidney Disease.
     Nephron. 2017 Oct 19. doi: 10.1159/000481892.
     PubMed     Abstract available
     
     
     September 2017
118. YANG CW
     Leptospirosis Renal Disease: Emerging Culprit of Chronic Kidney Disease Unknown Etiology.
     Nephron. 2017 Sep 20. doi: 10.1159/000480691.
     PubMed     Abstract available
     
     
     
119. VELOSO VSP, Ataides TL, Canziani MEF, Veloso MP, et al
     A Novel Missense GLA Mutation (p.G35V) Detected in Hemodialysis Screening Leads to Severe Systemic Manifestations of Fabry Disease in Men and Women.
     Nephron. 2017 Sep 12. doi: 10.1159/000479895.
     PubMed     Abstract available
     
     
     July 2017
120. CARRARA C, Abbate M, Sabadini E, Remuzzi G, et al
     Acute Kidney Injury and Hemolytic Anemia Secondary to Mycoplasma pneumoniae Infection.
     Nephron. 2017 Jul 7. doi: 10.1159/000478991.
     PubMed     Abstract available
     
     
     January 2017
121. 
     UK Renal Registry 19th Annual Report: Appendix E Methodology for Estimating Catchment Populations of Renal Centres in the UK for Dialysis Patients.
     Nephron. 2017;137 Suppl 1:347-350.
     PubMed    
     
     
     
122. HOLE B, Caskey F, Evans K, Fluck R, et al
     UK Renal Registry 19th Annual Report: Chapter 12 Multisite Dialysis Access Audit in England, Northern Ireland and Wales in 2015 and 2014 PD One Year Follow-up: National and Centre-specific Analyses.
     Nephron. 2017;137 Suppl 1:269-296.
     PubMed    
     
     
     
123. CROWLEY L, MacNeill S, Methven S, Nsonwu O, et al
     UK Renal Registry 19th Annual Report: Chapter 10 Epidemiology of Reported Infections in Patients Receiving Dialysis in England between January 2015 and December 2015: a Joint Report from Public Health England and the UK Renal Registry.
     Nephron. 2017;137 Suppl 1:251-258.
     PubMed    
     
     
     
124. METHVEN S, Perisanidou LI, Nicholas J, Dawnay A, et al
     UK Renal Registry 19th Annual Report: Chapter 8 Biochemical Variables amongst UK Adult Dialysis Patients in 2015: National and Centre-specific Analyses.
     Nephron. 2017;137 Suppl 1:189-234.
     PubMed    
     
     
     
125. FORD D, Gilg J, Williams AJ
     UK Renal Registry 19th Annual Report: Chapter 7 Haemoglobin, Ferritin and Erythropoietin amongst UK Adult Dialysis Patients in 2015: National and Centre-specific Analyses.
     Nephron. 2017;137 Suppl 1:165-188.
     PubMed    
     
     
     
126. HAMILTON AJ, Braddon F, Casula A, Lewis M, et al
     UK Renal Registry 19th Annual Report: Chapter 9 Clinical, Haematological and Biochemical Parameters in Patients on Renal Replacement Therapy in Paediatric Centres in the UK in 2015: National and Centre-specific Analyses.
     Nephron. 2017;137 Suppl 1:235-250.
     PubMed    
     
     
     
127. METHVEN S, Steenkamp R, Fraser S
     UK Renal Registry 19th Annual Report: Chapter 5 Survival and Causes of Death in UK Adult Patients on Renal Replacement Therapy in 2015: National and Centre-specific Analyses.
     Nephron. 2017;137 Suppl 1:117-150.
     PubMed    
     
     
     
128. HAMILTON AJ, Braddon F, Casula A, Lewis M, et al
     UK Renal Registry 19th Annual Report: Chapter 4 Demography of the UK Paediatric Renal Replacement Therapy Population in 2015.
     Nephron. 2017;137 Suppl 1:103-116.
     PubMed    
     
     
     
129. MACNEILL SJ, Ford D
     UK Renal Registry 19th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2015: National and Centre-specific Analyses.
     Nephron. 2017;137 Suppl 1:45-72.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: